Gregory T. Lucier

Chief Executive Officer

Greg Lucier founded Corza Health in partnership with leading private equity firm GTCR to combine his 30+ years of life sciences leadership with GTCR’s unrivaled track record of creating unique, value-generating private equity opportunities.

Greg most recently served as CEO at NuVasive, a world leader in minimally invasive spine surgery technology. Prior to that, he was CEO at Life Technologies—formerly Invitrogen—which he grew into a global life sciences powerhouse that was acquired by Thermo Fisher Scientific for approximately $15 billion. He spent the first part of his career with the General Electric Company in a variety of executive roles. 

Lucier remains the Chairman of Nuvasive, and serves on several public and private company boards, including Catalent, a leader in advanced pharmaceutical manufacturing services, Dentsply Sirona, a global provider of professional dental products and technologies, and Epic Sciences, a venture-backed company revolutionizing the use of cellular imaging to change cancer therapy.

Lucier holds a Bachelor’s in Industrial Engineering from Pennsylvania State University (graduating with distinction) and a Master’s in Business Administration from Harvard Business School.

In his free time, Greg enjoys riding motorcycles—both on and off-road—as well as skiing, which he is known to do anywhere and anytime he can.

Brian Berning

Chief Financial Officer

Brian Berning brings 20+ years of strategic financial leadership to Corza Health, where he leverages his expertise in M&A, operations, investor relations, corporate governance, risk management, and compliance to partner with management teams to accelerate growth and create significant value.

Brian most recently served as the CFO at GreatCall, the leading provider of connected health solutions for seniors. He successfully guided the company through its acquisition by GTCR in 2017 and ultimate sale to Best Buy a year later for $800 million.

Previously, as CFO at Human Longevity, a genomics and cellular therapy company, Berning helped the founders raise over $300 million and establish global operations.

Berning also served as SVP of Finance at LPL Financial, where he was the executive sponsor to the board for all operating efficiency initiatives and helped guide the company to a successful IPO. Brian began his career with Ernst & Young, LLP where he earned his CPA.

Brian holds a Bachelor’s in Business Administration from San Diego State University and a Master’s in Accounting from the University of Southern California.

As a San Diego native, Brian grew up surfing just a few steps from Corza Health’s headquarters. He continues to enjoy the outdoors and other adrenaline-inducing adventures to this day.

Brian Berning

Chief Financial Officer

Brian Berning brings 20+ years of strategic financial leadership to Corza Health, where he leverages his expertise in M&A, operations, investor relations, corporate governance, risk management, and compliance to partner with management teams to accelerate growth and create significant value.

Brian most recently served as the CFO at GreatCall, the leading provider of connected health solutions for seniors. He successfully guided the company through its acquisition by GTCR in 2017 and ultimate sale to Best Buy a year later for $800 million.

Previously, as CFO at Human Longevity, a genomics and cellular therapy company, Berning helped the founders raise over $300 million and establish global operations.

Berning also served as SVP of Finance at LPL Financial, where he was the executive sponsor to the board for all operating efficiency initiatives and helped guide the company to a successful IPO. Brian began his career with Ernst & Young, LLP where he earned his CPA.

Brian holds a Bachelor’s in Business Administration from San Diego State University and a Master’s in Accounting from the University of Southern California.

As a San Diego native, Brian grew up surfing just a few steps from Corza Health’s headquarters. He continues to enjoy the outdoors and other adrenaline-inducing adventures to this day.

Mark Gardner

SVP, Business Development

Mark Gardner adds 30+ years of executive leadership and scientific expertise to Corza Health. Mark works closely with Corza’s partners to formulate growth and integration plans, while also staying ahead of scientific and macroeconomic trends. Mark’s expertise includes life science research, molecular diagnostics, precision medicine, bioinformatics, and healthcare information technology.

Mark most recently served as CEO at OmniSeq, a molecular diagnostics spinout from Roswell Park Comprehensive Cancer Center, where he successfully grew the company’s revenues over 4x. He also completed a strategic partnership with LabCorp that resulted in investment capital and nationwide distribution of OmniSeq’s next-generation sequencing testing services.

Previously, Mark served as General Manager of several business segments at Thermo Fisher Scientific and Life Technologies, including the Ion Torrent next-generation sequencing franchise, the Animal Health and Food Safety division, the genetic analysis division, and the molecular biology essentials business. Mark led the due diligence efforts for Invitrogen to purchase Applied Biosystems (the merged company was rebranded as Life Technologies), Ion Torrent, and a variety of other businesses.

Prior to transitioning to the life sciences industry, Mark held management positions at GE Healthcare, McKinsey, and was a pilot in the United States Navy.

Mark holds a Bachelor’s in History from the United States Naval Academy, a Master’s of Business Administration (with Palmer Scholar Distinction) from the Wharton School at the University of Pennsylvania, and a Master’s in National Security Studies from Georgetown University.

Mark spent most of his childhood in Pittsburgh, PA and Rio de Janeiro, Brazil. He enjoys trail running, adventure travel with family, and smoking ribs and briskets.